Results 221 to 230 of about 195,699 (241)

Histamine release by platelet aggregation [PDF]

Agents and Actions, 1990
Coincubation of rat serosal mast cells with human platelets leads to a significant release of histamine. which dose-dependently increases when platelet aggregation is induced by various concentrations of arachidonic acid. In turn, histamine enhances platelet aggregation induced by different agonists, this effect being mimicked by pyridyl-ethyl-amine ...
P. F. Mannaioni, B. Palmerani, A. Pistelli, F. Gambassi, E. Giannella, SACCHI, TATIANA, MASINI, EMANUELA   +6 more
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Platelet Aggregation Studies

2009
In vitro platelet aggregation (PAGG) testing measures the response of platelets to added aggregating agents, or agonists, with measurements that primarily reflect activation, aggregation and, with some instruments, secretion. Traditionally, PAGG has been tested by light-transmission aggregometry (LTA), which measures the change in optical density of ...
openaire   +2 more sources

Piribedil and platelet aggregation.

Journal of medicine, 1984
Piribedil at high concentrations inhibits in vitro ADP and thrombin aggregation effect on the rabbit PRP.
VAIRO G, SCAFURO, Mariantonietta, LUCARELLI L, DI PAOLA E, MARMO E.   +4 more
openaire   +2 more sources

Platelet Aggregation: Methodology and Physiopathology

European Neurology, 1978
The physiopathological role of platelet aggregation in some thromboembolic and atherosclerotic complications is strongly suggested on the basis of many indirect findings. The qualitative methodological approach to this problem generally used until recently is rapidly giving way to a quantitative, biochemical approach.
de Gaetano G, Villa S, Livio M, DI MINNO, GIOVANNI   +3 more
openaire   +4 more sources

Plasma platelet aggregating factor and platelet aggregation studies in pre‐eclampsia

Acta Obstetricia et Gynecologica Scandinavica, 1996
Objective. A plasma platelet aggregating factor (PAF) has been implicated in the pathogenesis of platelet activation in thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). Similar mechanism may be operative in pre‐eclampsia. Methods.
Hara Prasad Pati, Sunita Ahlawat, Lali Fatima, Neerja Bhatla, Sunita Mittal   +4 more
openaire   +3 more sources

Platelet aggregation and platelet-inhibiting drugs

Neurochemical Pathology, 1987
Platelet function may cause a progression of central gray matter damage after cerebrospinal hemorrhage or trauma because of the thrombotic occlusion of injured vessels or a vasospasm induced by extravasated blood. It has therefore been suggested that antiplatelet drugs could limit the extent of the neurological lesions produced by a spinal trauma.
openaire   +2 more sources

Methods for Platelet Aggregation

1972
The property of platelets to aggregate with appropriate stimuli is an essential feature of the haemostatic and thrombotic process. The study of aggregation in vitro has contributed much to our understanding of this process. The introduction of an absorptiometer (3, 20) together with continuous recording of the changes in optical density (10) have ...
openaire   +3 more sources

RISTOCETIN AND PLATELET AGGREGATION

British Journal of Haematology, 1989
M. CATTANEO, M. CHIODINI, P. MANNUCCI
openaire   +3 more sources

Platelet Aggregation by Thimerosal [PDF]

Thrombosis and Haemostasis, 1976
openaire   +2 more sources

PLATELET AGGREGATION AND ANqSTHESIA

The Lancet, 1980
D. A. F. Chamone, Jozef Vermylen, A. Van Hoof   +2 more
openaire   +3 more sources